AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson
Blood Cancer Talks
Bispecific Antibodies in Lymphoma Treatment
This chapter discusses the use of bispecific antibodies in lymphoma treatment, their mechanism of action, side effects, and the comparison to bleanitumumab. It also explores the challenges of using bleanitumab and the promising results it showed in inducing complete remissions in patients with aggressive lymphomas.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode